Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

MARKSANS PHARMA LTD. - 524404 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2020 And Limited Review Reports Thereon.

 In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half year ended 30th September, 2020 approved by the Board of Directors at its meeting held today i.e. 6th November, 2020 along with Limited Review Reports thereon.
06-11-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 We enclose herewith Certificate issued by S. S. Rauthan & Associates, Company Secretaries for the half year ended 30th September, 2020 as required under Regulation 40(9) & 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
29-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Board Meeting Intimation for Notice Of Board Meeting

 MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and half year ended 30th September, 2020.
28-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2020

 Please find enclosed herewith Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 30th September, 2020.
14-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Shareholding for the Period Ended September 30, 2020

 Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
14-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2020 received from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company.
14-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer
09-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 As attached
03-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Marksans Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-10-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Please find enclosed herewith the results of the voting conducted through remote e-voting during 26th September, 2020 to 28th September, 2020 (both days inclusive) and remote e-voting during the 28th Annual General Meeting of Marksans Pharma Limited held on 29th September, 2020 through video conferencing along with Consolidated report of the Scrutinizer.
30-09-2020
Next Page
Close

Let's Open Free Demat Account